-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Vir Biotechnology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2024.
- Vir Biotechnology, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$117M, a 15.7% increase year-over-year.
- Vir Biotechnology, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$587M, a 14.2% increase year-over-year.
- Vir Biotechnology, Inc. annual Operating Income (Loss) for 2024 was -$587M, a 14.2% increase from 2023.
- Vir Biotechnology, Inc. annual Operating Income (Loss) for 2023 was -$684M, a 182% decline from 2022.
- Vir Biotechnology, Inc. annual Operating Income (Loss) for 2022 was $833M, a 98% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)